What is the main business of Forclever?

The main business activity of Forclever focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on January 8, 2019.

Where is the headquarters located?

The headquarters is located at: ul. 3 Maja 18A, 05-504 Złotokłos.

What is the share capital?

The share capital of the company is PLN 50,000 (approx. $13,506).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2022 to December 31, 2022.

How much revenue was generated?

In 2022, the company's revenue reached $0.

No, the company recorded a net loss of $1,803 in 2022.

What is the largest operating cost?

The largest operating cost category falls under external services. This category amounted to $1,566 in 2022, representing 87% of all operating expenses.

Forcleversp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2019-01-08

Share capital

50,000.00 PLN

Activity description

Forclever distributes medical devices and products for regenerative medicine and rehabilitation. Its portfolio serves orthopedics, veterinary orthopedics, aesthetic medicine, and dentistry.

Registered address

ul. 3 Maja 18A, 05-504 Złotokłos, Poland

Website

forclever.pl

Phone

Social media

Electronic delivery address

AE:PL-38221-27766-WJGTI-33

Financials

Revenue history

Filing timeliness

No financial statement for 2023 – the filing deadline has passed. 1 of 4 financial statements was filed late (for 2022, 2 days late), 1 not filed.

2023not filed
202217/07/2023
2021not filed
202012/08/2021
201931/07/2020

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2022.

Results vs industry

Revenue

This companyUSD 0.04MedianUSD 1.06mAverageUSD 22.41m

Net profit

This companyUSD -1.80kMedianUSD 37.20kAverageUSD 879.46k

Operating costs

This companyUSD 1.80kMedianUSD 921.66kAverageUSD 21.08m

Assets

This companyUSD 4.02kMedianUSD 609.79kAverageUSD 11.85m

Industry

Wholesale of pharmaceutical goods (46.46.Z)Primary

Authorized Representatives

Monika Wanda Niemiro – President of the Management Board

Paweł Niemiro – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Monika Wanda Niemiroage 52	510	$6,888.17	51%
Paweł Niemiroage 46	490	$6,618.04	49%

Monika Wanda Niemiro and Paweł Niemiro hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2019-04-02.

No bank accounts reported to the VAT Taxpayer Register.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
May 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,282$1,282	Starosta Piaseczyński

Competitors

Name	Revenue	Website
Quercus Pharmasp. z o.o.	$0.42	quercuspharma.com
Prime Next Generationsp. z o.o.	$0.31	prime-next-generation.pl
Amarox Pharmasp. z o.o.	$0.31	amaroxpharma.pl
ITER Pharmasp. z o.o.	$0.17	iterpharma.pl
Novaovasp. z o.o.	$0.16	novaova.pl
Revital Medicasp. z o.o.	$0.10	revitalmedica.com.pl
Euro Eco Foodsp. z o.o.	$0.07	euroecofood.pl